Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice

Atherosclerosis

Volumn 238, Issue 2, 2015, Pages 278-288

  Yu, Kunwu ^a   Dong, Qian ^a   Mao, Xiaobo ^a   Meng, Kai ^a   Zhao, Xiaoqi ^a   Ji, Qingwei ^b,c   Wu, Bangwei ^d   Zhong, Yucheng ^a   Zhu, Zhengfeng ^a   Liu, Yuzhou ^a   Zhang, Wei ^a   Tony, Hasahya ^a   Shi, Huairui ^a   Zeng, Qiutang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; Dendritic cell; Low density lipoprotein (LDL); Regulatory T cell (Treg); Thymic stromal lymphopoietin (TSLP)

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE RECEPTOR; INTERLEUKIN 1BETA; LATENCY ASSOCIATED PEPTIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROGRAMMED DEATH 1 LIGAND 1; RETINOID X RECEPTOR ALPHA; THYMIC STROMAL LYMPHOPOIETIN; THYMIC STROMAL LYMPHOPOIETIN RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN; PEPTIDE; TSLPR PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM CELL; EX VIVO STUDY; HOMEOSTASIS; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN; THYMUS; UPREGULATION; AGONISTS; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; HYPERLIPIDEMIAS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; LIPOPROTEINS, LDL; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84921286939     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.12.019     Document Type: Article

References (58)

1. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev. Pathol. 2006, 1:297-329.
2. Nilsson J. Regulating protective immunity in atherosclerosis. Circ. Res. 2005, 96(4):395-397.
3. Hansson G.K., Nilsson J. Introduction: atherosclerosis as inflammation: a controversial concept becomes accepted. J.Intern. Med. 2008, 263(5):462-463.
4. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102(24):2919-2922.
5. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J.Clin. Invest. 1997, 99(11):2752-2761.
6. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212:8-27.
7. Sasaki N., Yamashita T., Takeda M., Shinohara M., Nakajima K., Tawa H., et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009, 120(20):1996-2005.
8. Mor A., Luboshits G., Planer D., Keren G., George J. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 2006, 27(21):2530-2537.
9. de Boer O.J., van der Meer J.J., Teeling P., van der Loos C.M., van der Wal A.C. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007, 2(8):e779.
10. Mor A., Planer D., Luboshits G., Afek A., Metzger S., Chajek-Shaul T., et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27(4):893-900.
11. Ait-Oufella H., Salomon B.L., Potteaux S., Robertson A.K., Gourdy P., Zoll J., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 2006, 12(2):178-180.
12. Feng J., Zhang Z., Kong W., Liu B., Xu Q., Wang X. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice. Cardiovasc. Res. 2009, 84(1):155-163.
13. Josefowicz S.Z., Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30(5):616-625.
14. Tang T.T., Zhu Z.F., Wang J., Zhang W.C., Tu X., Xiao H., et al. Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure. PLoS One 2011, 6(9):e24272.
15. Zhang W.C., Wang J., Shu Y.W., Tang T.T., Zhu Z.F., Xia N., et al. Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome. J.Biol. Chem. 2012, 287(41):34157-34166.
16. Reche P.A., Soumelis V., Gorman D.M., Clifford T., Liu M., Travis M., et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J.Immunol. 2001, 167(1):336-343.
17. Taylor B.C., Zaph C., Troy A.E., Du Y., Guild K.J., Comeau M.R., et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J.Exp. Med. 2009, 206(3):655-667.
18. Watanabe N., Wang Y.H., Lee H.K., Ito T., Wang Y.H., Cao W., et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436(7054):1181-1185.
19. Jiang Q., Su H., Knudsen G., Helms W., Su L. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. BMC Immunol. 2006, 7:6.
20. Haas J., Korporal M., Schwarz A., Balint B., Wildemann B. The interleukin-7 receptor alpha chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis. Eur. J. Immunol. 2011, 41(3):845-853.
21. Yu K., Zhu P., Dong Q., Zhong Y., Zhu Z., Lin Y., et al. Thymic stromal lymphopoietin attenuates the development of atherosclerosis in ApoE-/- mice. J.Am. Heart Assoc. 2013, 2(5):e391.
22. Zhu Z.F., Meng K., Zhong Y.C., Qi L., Mao X.B., Yu K.W., et al. Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. PLoS One 2014, 9(2):e88775.
23. Duan W., So T., Mehta A.K., Choi H., Croft M. Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation. J.Immunol. 2011, 187(12):6499-6507.
24. Hazenberg M.D., Verschuren M.C., Hamann D., Miedema F., van Dongen J.J. Tcell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J.Mol. Med. Berl. 2001, 79(11):631-640.
25. Yilmaz A., Weber J., Cicha I., Stumpf C., Klein M., Raithel D., et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J.Am. Coll. Cardiol. 2006, 48(1):70-80.
26. Dietel B., Cicha I., Voskens C.J., Verhoeven E., Achenbach S., Garlichs C.D. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 2013, 230(1):92-99.
27. Schuepbach-Mallepell S., Philippe V., Bruggen M.C., Watanabe H., Roques S., Baldeschi C., et al. Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin. J.Allergy Clin. Immunol. 2013, 132(6):1348-1357.
28. Li M., Messaddeq N., Teletin M., Pasquali J.L., Metzger D., Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(41):14795-14800.
29. Shin H.K., Kim Y.K., Kim K.Y., Lee J.H., Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 2004, 109(8):1022-1028.
30. Clarke M.C., Talib S., Figg N.L., Bennett M.R. Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ. Res. 2010, 106(2):363-372.
31. Lee J.Y., Lim Y.M., Park M.J., Min S.Y., Cho M.L., Sung Y.C., et al. Murine thymic stromal lymphopoietin promotes the differentiation of regulatory T cells from thymic CD4(+)CD8(-)CD25(-) naive cells in a dendritic cell-independent manner. Immunol. Cell. Biol. 2008, 86(2):206-213.
32. Reis E.S.C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6(6):476-483.
33. Gandhi R., Anderson D.E., Weiner H.L. Cutting Edge: immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner. J.Immunol. 2007, 178(7):4017-4021.
34. Kong F.K., Chen C.L., Six A., Hockett R.D., Cooper M.D. Tcell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(4):1536-1540.
35. Haas J., Fritzsching B., Trubswetter P., Korporal M., Milkova L., Fritz B., et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J.Immunol. 2007, 179(2):1322-1330.
36. Valmori D., Merlo A., Souleimanian N.E., Hesdorffer C.S., Ayyoub M. Aperipheral circulating compartment of natural naive CD4 Tregs. J.Clin. Invest. 2005, 115(7):1953-1962.
37. Sempowski G.D., Gooding M.E., Liao H.X., Le P.T., Haynes B.F. Tcell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol. 2002, 38(11):841-848.
38. Vukmanovic-Stejic M., Zhang Y., Cook J.E., Fletcher J.M., McQuaid A., Masters J.E., et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations invivo. J.Clin. Invest. 2006, 116(9):2423-2433.
39. Gregg R., Smith C.M., Clark F.J., Dunnion D., Khan N., Chakraverty R., et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin. Exp. Immunol. 2005, 140(3):540-546.
40. Fiorina P., Jurewicz M., Tanaka K., Behazin N., Augello A., Vergani A., et al. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong isletallograft survival. Diabetes 2007, 56(4):912-920.
41. Fiorina P., Jurewicz M., Vergani A., Augello A., Paez J., Ricchiuti V., et al. Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation. Transplantation 2008, 85(7):1030-1038.
42. Proietto A.I., van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R.J., et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(50):19869-19874.
43. Yamazaki S., Dudziak D., Heidkamp G.F., Fiorese C., Bonito A.J., Inaba K., et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J.Immunol. 2008, 181(10):6923-6933.
44. Oldenhove G., de Heusch M., Urbain-Vansanten G., Urbain J., Maliszewski C., Leo O., et al. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells invivo. J.Exp. Med. 2003, 198(2):259-266.
45. Van Vre E.A., Bosmans J.M., Van Brussel I., Maris M., De Meyer G.R., Van Schil P.E., et al. Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. Pathology 2011, 43(3):239-247.
46. Hermansson A., Johansson D.K., Ketelhuth D.F., Andersson J., Zhou X., Hansson G.K. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011, 123(10):1083-1091.
47. Daissormont I.T., Christ A., Temmerman L., Sampedro M.S., Seijkens T., Manca M., et al. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ. Res. 2011, 109(12):1387-1395.
48. Weber C., Meiler S., Doring Y., Koch M., Drechsler M., Megens R.T., et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J.Clin. Invest. 2011, 121(7):2898-2910.
49. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J.Exp. Med. 2003, 198(12):1875-1886.
50. Nishiura H., Kido M., Aoki N., Iwamoto S., Maruoka R., Ikeda A., et al. Increased susceptibility to autoimmune gastritis in thymic stromal lymphopoietin receptor-deficient mice. J.Immunol. 2012, 188(1):190-197.
51. Turcot V., Bouchard L., Faucher G., Garneau V., Tchernof A., Deshaies Y., et al. Thymic stromal lymphopoietin: an immune cytokine gene associated with the metabolic syndrome and blood pressure in severe obesity. Clin. Sci. Lond. 2012, 123(2):99-109.
52. Miller Y.I., Chang M.K., Binder C.J., Shaw P.X., Witztum J.L. Oxidized low density lipoprotein and innate immune receptors. Curr. Opin. Lipidol. 2003, 14(5):437-445.
53. Da C.T., Sardinha L.R., Larocca R., Peron J.P., Rizzo L.V. Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells. Immunology 2011, 133(1):123-132.
54. Lee J., Zhuang Y., Wei X., Shang F., Wang J., Zhang Y., et al. Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis. J.Mol. Cell. Cardiol. 2009, 46(2):169-176.
55. Gotsman I., Grabie N., Dacosta R., Sukhova G., Sharpe A., Lichtman A.H. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J.Clin. Invest. 2007, 117(10):2974-2982.
56. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23(4):656-660.
57. Zhang K., Shan L., Rahman M.S., Unruh H., Halayko A.J., Gounni A.S. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293(2):L375-L382.
58. Spadoni I., Iliev I.D., Rossi G., Rescigno M. Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis. Mucosal Immunol. 2012, 5(2):184-193.